- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Booster Vaccine For Omicron Variant Gets Emergency Use Approval
It is a thermostable vaccine, which does not require ultra-cold chain infrastructure used for other approved mRNA-based vaccines
Photo Credit :
The booster vaccine GEMCOVAC®-OM, developed to provide immunity against the Omicron variant of Covid-19, has received approval from the regulator Drug Control General of India (DCGI) for emergency use.
The mRNA-based vaccine was developed using the indigenous platform technology by Gennova Biopharmaceuticals and supported under the Mission Covid Suraksha, implemented by Biotechnology Industry Research Assistance Council (BIRAC), said a Ministry of Science and Technology release.
It is a thermostable vaccine, which does not require ultra-cold chain infrastructure used for other approved mRNA-based vaccines, making it easy for deployment across the country.
"It is delivered intra-dermally using a needle-free injection device system. When administered intradermally in participants as a booster, it generated significantly higher immune responses. The clinical outcome demonstrates the need for variant-specific vaccines for desired immune response," the release said. (ANI)